Literature DB >> 17949688

Thrombin regulates the function of human blood dendritic cells.

Manabu Yanagita1, Ryohei Kobayashi, Yoichiro Kashiwagi, Yoshio Shimabukuro, Shinya Murakami.   

Abstract

Thrombin is the key enzyme in the coagulation cascade and activates endothelial cells, neutrophils and monocytes via protease-activated receptors (PARs). At the inflammatory site, immune cells have an opportunity to encounter thrombin. However little is known about the effect of thrombin for dendritic cells (DC), which are efficient antigen-presenting cells and play important roles in initiating and regulating immune responses. The present study revealed that thrombin has the ability to stimulate blood DC. Plasmacytoid DC (PDC) and myeloid DC (MDC) isolated from PBMC expressed PAR-1 and released MCP-1, IL-10, and IL-12 after thrombin stimulation. Unlike blood DC, monocyte-derived DC (MoDC), differentiated in vitro did not express PAR-1 and were unresponsive to thrombin. Effects of thrombin on blood DC were significantly diminished by the addition of anti-PAR-1 Ab or hirudin, serine protease inhibitor. Moreover, thrombin induced HLA-DR and CD86 expression on DC and the thrombin-treated DC induced allogenic T cell proliferation. These findings indicate that thrombin plays a role in the regulation of blood DC functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949688     DOI: 10.1016/j.bbrc.2007.10.002

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Thrombin induces an inflammatory phenotype in a human brain endothelial cell line.

Authors:  Leah M Alabanza; Margaret S Bynoe
Journal:  J Neuroimmunol       Date:  2012-02-29       Impact factor: 3.478

2.  Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells.

Authors:  Corin Ezzelarab; David Ayares; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2012-09-13       Impact factor: 3.907

3.  Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy.

Authors:  S Della Bella; S Giannelli; V Cozzi; V Signorelli; M Cappelletti; I Cetin; M L Villa
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

Review 4.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

Review 5.  Interface between hemostasis and adaptive immunity.

Authors:  Zheng Qu; Elliot L Chaikof
Journal:  Curr Opin Immunol       Date:  2010-10-11       Impact factor: 7.486

Review 6.  Systemic inflammation in xenograft recipients (SIXR): A new paradigm in pig-to-primate xenotransplantation?

Authors:  Mohamed B Ezzelarab; David K C Cooper
Journal:  Int J Surg       Date:  2015-07-21       Impact factor: 6.071

Review 7.  Thrombin generation and activity in multiple sclerosis.

Authors:  Kelley R Jordan; Ivan Parra-Izquierdo; András Gruber; Joseph J Shatzel; Peter Pham; Larry S Sherman; Owen J T McCarty; Norah G Verbout
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

8.  Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.

Authors:  Laetitia Aerts; Marie-Ève Hamelin; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Woojin Kim; Delia Susan-Resiga; Annik Prat; Nabil G Seidah; Nathalie Vergnolle; Beatrice Riteau; Guy Boivin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 9.  Evaluation on potential contributions of protease activated receptors related mediators in allergic inflammation.

Authors:  Huiyun Zhang; Xiaoning Zeng; Shaoheng He
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

Review 10.  Coagulation and Fibrinolysis in Kidney Graft Rejection.

Authors:  Giovanni Stallone; Paola Pontrelli; Federica Rascio; Giuseppe Castellano; Loreto Gesualdo; Giuseppe Grandaliano
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.